Chronic Kidney Disease in Diabetes: New Research on Early Detection and Prevention
Quick Facts
Why Is Diabetic Kidney Disease So Difficult to Detect Early?
Diabetic kidney disease, also known as diabetic nephropathy, remains one of the most serious complications of both type 1 and type 2 diabetes. According to the NIDDK, diabetes is responsible for approximately 40 percent of all cases of kidney failure in the United States. The challenge lies in the fact that significant kidney damage can accumulate before patients notice any symptoms, often only becoming apparent when the disease has reached an advanced stage.
Current screening relies primarily on urine albumin-to-creatinine ratio (UACR) and estimated glomerular filtration rate (eGFR), but these markers may not capture the earliest stages of kidney injury. NIDDK-funded researchers are investigating novel biomarkers — including kidney injury molecule-1 (KIM-1) and tumor necrosis factor receptors — that may detect damage years before traditional tests show abnormalities. Early identification could open a critical window for intervention when treatments are most effective.
What Treatments Are Showing Promise for Slowing Kidney Disease Progression?
The treatment landscape for diabetic kidney disease has expanded significantly in recent years. SGLT2 inhibitors, originally developed as glucose-lowering medications, have shown remarkable kidney-protective effects in major trials such as CREDENCE and DAPA-CKD. These drugs reduce the risk of kidney disease progression by approximately 30 to 40 percent, according to published trial data. The FDA has approved several SGLT2 inhibitors specifically for chronic kidney disease indications.
Additionally, finerenone, a nonsteroidal mineralocorticoid receptor antagonist, demonstrated kidney and cardiovascular benefits in the FIDELIO-DKD and FIGARO-DKD trials. NIDDK-supported research is now exploring whether combining these newer agents with established therapies like ACE inhibitors or ARBs can provide additive protection. Researchers are also investigating GLP-1 receptor agonists for potential direct kidney benefits beyond their metabolic effects, with several clinical trials underway.
How Can Patients With Diabetes Protect Their Kidney Health?
The NIDDK emphasizes that managing blood glucose levels and blood pressure remains the cornerstone of preventing diabetic kidney disease. The American Diabetes Association recommends that all patients with type 2 diabetes be screened annually for kidney disease starting at diagnosis, and patients with type 1 diabetes should begin screening five years after diagnosis. Blood pressure targets below 130/80 mmHg are generally recommended for people with diabetes and kidney disease.
Lifestyle modifications also play an important role. Reducing sodium intake, maintaining a healthy weight, engaging in regular physical activity, and avoiding nephrotoxic medications such as nonsteroidal anti-inflammatory drugs (NSAIDs) can all help preserve kidney function. Smoking cessation is particularly important, as smoking accelerates kidney damage in people with diabetes. Patients should work closely with their healthcare providers to develop individualized management plans that incorporate both lifestyle changes and appropriate pharmacological therapies.
Frequently Asked Questions
The American Diabetes Association recommends annual kidney screening with a urine albumin test and a blood test for eGFR. People with type 2 diabetes should be screened from diagnosis, while those with type 1 diabetes should start five years after diagnosis. More frequent testing may be needed if abnormalities are detected.
Early-stage diabetic kidney disease can sometimes be stabilized or partially reversed with aggressive blood sugar and blood pressure control, along with appropriate medications. However, advanced kidney damage is generally irreversible. This is why early detection and intervention are critical to preserving kidney function.
Diet is an important component of management. Reducing sodium intake helps control blood pressure, and moderating protein intake may reduce strain on damaged kidneys. A registered dietitian can help create individualized meal plans. The NIDDK recommends working with healthcare providers before making significant dietary changes.
References
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Diabetic Kidney Disease. National Institutes of Health.
- American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2025.
- Heerspink HJL et al. Dapagliflozin in Patients with Chronic Kidney Disease (DAPA-CKD). New England Journal of Medicine. 2020.